Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells

References

• ACS. About pancreatic cancer. American Cancer Society https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html: American Cancer Society; 2017
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• Oberstein PE, Olive KP. Pancreatic cancer: why is it so hard to treat? Therap Adv Gastroenterol. 2013;6:321–337.
   PubMed Web of Science ®Google Scholar
• Fjallskog ML, Lejonklou MH, Oberg KE, et al. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin Cancer Res. 2003;9:1469–1473.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Banerjee S, Wang Z, et al. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Res. 2006;66:1025–1032.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–398.
   PubMed Web of Science ®Google Scholar
• Masuda T, Maekawa T, Hidaka K, et al. Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. J Agric Food Chem. 2001;49:2539–2547.
   PubMed Web of Science ®Google Scholar
• Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44:97–111.
   PubMed Web of Science ®Google Scholar
• Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 1999;39:41–47.
   PubMed Web of Science ®Google Scholar
• Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol. 2007;595:213–226.
   PubMed Web of Science ®Google Scholar
• LoTempio MM, Veena MS, Steele HL, et al. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res. 2005;11:6994–7002.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007;67:3853–3861.
   PubMed Web of Science ®Google Scholar
• Zong H, Wang F, Fan QX, et al. Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep. 2012;39:4803–4808.
   PubMed Web of Science ®Google Scholar
• Liu S, Wang Z, Hu Z, et al. Anti-tumor activity of curcumin against androgen-independent prostate cancer cells via inhibition of NF-kappaB and AP-1 pathway in vitro. J Huazhong Univ Sci Technol. 2011;31:530–534.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy K, Goud VK, Sesikeran B, et al. Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin. Nutr Cancer. 1998;30:163–166.
   PubMed Web of Science ®Google Scholar
• Inano H, Onoda M, Inafuku N, et al. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis. 1999;20:1011–1018.
   PubMed Web of Science ®Google Scholar
• Collett GP, Robson CN, Mathers JC, et al. Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis. 2001;22:821–825.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Diagaradjane P, Anand P, et al. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer. 2009;125:2187–2197.
   PubMed Web of Science ®Google Scholar
• Tharakan ST, Inamoto T, Sung B, et al. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem Pharmacol. 2010;79:218–228.
   PubMed Web of Science ®Google Scholar
• Park CH, Lee JH, Yang CH. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues. J Biochem Mol Biol. 2005;38:474–480.
   PubMedGoogle Scholar
• Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–157.
   PubMed Web of Science ®Google Scholar
• Lu HF, Lai KC, Hsu SC, et al. Curcumin induces apoptosis through FAS and FADD, in caspase-3-dependent and -independent pathways in the N18 mouse-rat hybrid retina ganglion cells. Oncol Rep. 2009;22:97–104.
   PubMed Web of Science ®Google Scholar
• Jia YL, Li J, Qin ZH, et al. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res. 2009;11:918–928.
   PubMed Web of Science ®Google Scholar
• O’Sullivan-Coyne G, O’Sullivan GC, O’Donovan TR, et al. Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer. 2009;101:1585–1595.
   PubMed Web of Science ®Google Scholar
• Yoysungnoen P, Wirachwong P, Bhattarakosol P, et al. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc. 2006;34:109–115.
   PubMed Web of Science ®Google Scholar
• Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68:3645–3654.
   PubMed Web of Science ®Google Scholar
• Yodkeeree S, Ampasavate C, Sung B, et al. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol. 2010;627:8–15.
   PubMed Web of Science ®Google Scholar
• Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491–4499.
   PubMed Web of Science ®Google Scholar
• Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol. 2011;68:157–164.
   PubMed Web of Science ®Google Scholar
• Epelbaum R, Schaffer M, Vizel B, et al. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer. 2010;62:1137–1141.
   PubMed Web of Science ®Google Scholar
• Marczylo TH, Verschoyle RD, Cooke DN, et al. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 2007;60:171–177.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yasunaga Y, Segawa T, et al. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol. 2002;21:825–830.
   PubMed Web of Science ®Google Scholar
• Zupancic S, Kocbek P, Zariwala MG, et al. Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. Mol Pharmaceutics. 2014;11:2334–2345.
   PubMed Web of Science ®Google Scholar
• Ahmadi Nasab N, Hassani Kumleh H, Beygzadeh M, et al. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 2017 [Feb 23]; [7 p.]. DOI:10.1080/21691401.2017.1290648
   PubMed Web of Science ®Google Scholar
• Rejinold NS, Sreerekha PR, Chennazhi KP, et al. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. Int J Biol Macromol. 2011;49:161–172.
   PubMed Web of Science ®Google Scholar
• Ucisik MH, Kupcu S, Schuster B, et al. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. J Nanobiotechnology. 2013;11:37.
   PubMed Web of Science ®Google Scholar
• Reeves A, Vinogradov SV, Morrissey P, et al. Curcumin-encapsulating nanogels as an effective anticancer formulation for intracellular uptake. Mol Cell Pharmacol. 2015;7:25–40.
   PubMedGoogle Scholar
• Mourtas S, Canovi M, Zona C, et al. Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide . Biomaterials. 2011;32:1635–1645.
   PubMed Web of Science ®Google Scholar
• Basnet P, Hussain H, Tho I, et al. Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci. 2012;101:598–609.
   PubMed Web of Science ®Google Scholar
• Narayanan NK, Nargi D, Randolph C, et al. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer. 2009;125:1–8.
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104:1322–1331.
   PubMed Web of Science ®Google Scholar
• Le UM, Cui Z. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. Int J Pharm. 2006;312:105–112.
   PubMedGoogle Scholar
• Beuttler J, Rothdiener M, Muller D, et al. Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL). Bioconjugate Chem. 2009;20:1201–1208.
   PubMed Web of Science ®Google Scholar
• Sandoval MA, Sloat BR, Lansakara PD, et al. EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity. J Control Release. 2012;157:287–296.
   PubMed Web of Science ®Google Scholar
• Thangapazham RL, Shaheduzzaman S, Kim KH, et al. Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome. Cancer Biol Ther. 2008;7:1427–1435.
   PubMed Web of Science ®Google Scholar
• Thangapazham RL, Puri A, Tele S, et al. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol. 2008;32:1119–1123.
   PubMed Web of Science ®Google Scholar
• Wang F, Huang W. Determination of curcumin by its quenching effect on the fluorescence of Eu3+-tryptophan complex. J Pharm Biomed Anal. 2007;43:393–398.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qi Z, Huang Q, et al. Imprinted-like biopolymeric micelles as efficient nanovehicles for curcumin delivery. Colloids Surf B Biointerfaces. 2014;123:15–22.
   PubMed Web of Science ®Google Scholar
• Spitzer E, de Los Angeles M, Perez R, et al. Binding properties of biotinylated epidermal growth factor to its receptor on cultured cells and tissue sections. J Cell Biochem. 1989;41:47–56.
   PubMed Web of Science ®Google Scholar
• French AR, Tadaki DK, Niyogi SK, et al. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem. 1995;270:4334–4340.
   PubMed Web of Science ®Google Scholar
• Ali S, El-Rayes BF, Sarkar FH, et al. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy. Mol Cancer Ther. 2005;4:1943–1951.
   PubMed Web of Science ®Google Scholar
• Tobita K, Kijima H, Dowaki S, et al. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis. Int J Mol Med. 2003;11:305–309.
   PubMed Web of Science ®Google Scholar
• Goldman CK, Kim J, Wong WL, et al. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell. 1993;4:121–133.
   PubMed Web of Science ®Google Scholar
• Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25:1960–1966.
   PubMed Web of Science ®Google Scholar
• Bohl Kullberg E, Bergstrand N, Carlsson J, et al. Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjug Chem. 2002;13:737–743.
   PubMed Web of Science ®Google Scholar